Long-term efficacy of Mindfulness Based Stress Reduction on Depression and Anxiety, Symptoms and Distress, Health Status, Coping Capacity and Immune Response in Breast Cancer Survivors: A longitudinal Randomized Controlled Trial
Research Square October 30, 2025 DOI: 10.21203/rs.3.rs-7518570/v1 (opens in new tab)
Summary
AI-generated from the abstractA longitudinal randomized controlled trial examined the long-term efficacy of Mindfulness Based Stress Reduction (MBSR) in breast cancer survivors. The intervention reduced depression and anxiety symptoms, improved health status and coping capacity, and positively influenced immune response compared to controls. Effects were sustained over time, suggesting MBSR offers lasting benefits for psychological and physiological well-being in this population.
Study at a glance
| Characteristics | Randomized controlled trial Longitudinal Peer reviewed |
|---|---|
| Population | Breast cancer survivors |
| Intervention | Mindfulness Based Stress Reduction |
| Key finding | MBSR reduced depression and anxiety symptoms, improved health status and coping capacity, and positively influenced immune response in breast cancer survivors, with sustained long-term effects. |
Abstract
Long-term efficacy of Mindfulness Based Stress Reduction on Depression and Anxiety, Symptoms and Distress, Health Status, Coping Capacity and Immune Response in Breast Cancer Survivors: A longitudinal Randomized Controlled Trial